Revenue Forecast For Investigational Therapeutic – Free Tool
February 19, 2020
BioHeights has launched a new tool that allows to forecast revenue for an investigational therapeutic. In the main menu, go to Tools – Revenue Forecast Calculator.

Why should you give it a try? Building your own drug revenue forecast model from scratch is time consuming. Instead, you can test your product and market assumptions using our flexible tool.

The tool has 5 key features
  • The tool accommodates multiple disease indications
  • Built-in prevalence and incidence data for over 170 diseases
  • Current version allows users to toggle between U.S., EU5, and Japan
  • It accommodates both basic and advanced inputs. All inputs could be over-written by user
  • Graphical output overlays all indications and displays maximum annual revenue forecast. Responsive graphical output reacts immediately to changes in input(s)

Basic Inputs

Basic modifiable inputs include Market and Product assumptions, while overall country populations are taken from Worldometers.

Market Inputs
  • Prevalence and Incidence. Users can choose whether Prevalence or Incidence rate is driving sales in each specific disease market
  • Addressable Patient Segment. Obviously, not all patients with the disease will need or be eligible to receive a product
Product Inputs
  • Expected Launch Year, which depends on current status of development and projected timeline
  • Year of expected Loss of Exclusivity, which is dependent on the underlying intellectual property, as well as any received designations related to extending exclusivity
  • The expected number of Years to Peak Penetration. This parameter reflects how slow or fast the drug will reach all its addressable patient population and maximum market share
  • Expected Product Share (i.e., market share)
  • The number of Doses per patient per year
  • Finally, Price per Dose
Advanced Options

Additionally, the tool features advanced input options for product and market assumptions. Market assumptions include Prevalence/Incidence annual growth rates, Diagnosis and Treatment rates, more granular patient segmentation. Product assumptions include Payer Coverage, remaining % of revenue after the Loss of Exclusivity, additional competitive market share, Drug Discontinuation inputs, Discounts/Rebates, and annual Price Growth Rate.

Finally, for further description, hover over ‘?’ sign next to each input parameter.

Disclaimer: This tool is the property of BioHeights LLC. The model is designed only for educational purposes. This is not a financial advice. BioHeights LLC and its members are not responsible for anybody’s actions, losses, or damages resulting from using this tool.

Try it and shoot us an email at with any questions, comments, request, and feedback. We look forward to hearing about your experience with the tool.
Sickle Cell Disease: Centers of Excellence And Gene Therapy
July 11, 2020
Ohio Cell and Vector Manufacturing Landscape
May 15, 2020
Educational Webinars: Forecasting Principles And Tools
April 8, 2020
Risk-Adjusted NPV Calculator – Free Tool
March 21, 2020
NRA NPV Forecast For Investigational Product – Free Tool
March 11, 2020
CAR T Release Testing Basics
February 21, 2020
Revenue Forecast For Investigational Therapeutic – Free Tool
February 19, 2020
The Man Who Speaks on Behalf of ALL Children
October 17, 2019
Anti-CD19 CAR T Kymriah and Yescarta Race to Market Infographic
September 1, 2019
Jeff Marrazzo Tells His Spark Story
July 1, 2019
ASGCT 2019 Insights: Cell and Gene Therapies Tackle 160+ Disorders
May 10, 2019
AAV Gene Therapy Clinical Trials Target Over 50 Diseases
April 1, 2019
13 Different Routes of Administration in AAV Gene Therapy Clinical Trials
March 1, 2019